TRENDING :  Market Movers  |  Top 50   SPY (0.23%)    TSLA (-2.49%)    CANF (1.36%)    BYND (-2.96%)    BTCUSD (%)    ONCS (-3.12%)    AMZN (0.43%)    TVIX (-4.25%)    VXX (-2.07%)    ROKU (6.45%)    ACAD (2.45%)    OIH (-1.43%)    MCHP (-1.44%)    MAXR (-13.79%)    IRBT (0.03%)    IP (-0.24%)    INTC (0.09%)    GDX (0.64%)    FTNT (0.33%)    ECOR (-4.53%)    DNR (3.23%)    DIS (0.05%)    DFRG (2.06%)    CMG (-0.69%)    BIOC (9.74%)

 AKBA - Akebia Therapeutics

$5.24 [-0.02][-0.39%]

Next Earnings

8/7/2019

AMC

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

3


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $9.00
Low $9.00
Average $9.00
Current $5.24

CompanyAnalyst NamePT ActionActionRatingTargetDate
CitigroupAnnouncesInitiates Coverage OnHold$9.0003/20/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $AKBA

Service NameTrader% Success
Alpha Swing TradesJonathan69.00 %Follow

TRENDING ARTICLES



Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call Transcript

05/09/19
Image source The Motley Fool Akebia Therapeutics Inc NASDAQ AKBA Q1 2019 Earnings Call May 9 2019 9 00 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator Good

Akebia Therapeutics (AKBA) Reports Q1 Loss, Lags Revenue Estimates

05/09/19
Akebia Therapeutics AKBA came out with a quarterly loss of 0 44 per share versus the Zacks Consensus Estimate of a loss of 0 42 This compares to loss of 0 48 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise

Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week? What You Should Know

05/02/19
Wall Street expects a year over year increase in earnings on higher revenues when Akebia Therapeutics AKBA reports results for the quarter ended March 2019 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that could impact